Donate For Public and Patients Store Search

American Academy of Dermatology Logo

Measure 410

Psoriasis: Clinical Response to Systemic Medications

Description: The percentage of psoriasis vulgaris patients receiving systemic medication who meet minimal physician- or patient-reported disease activity levels.

Measure ID: 410

Type: Outcome

CMS Derm Specialty Set: Yes

Priority: Yes

Topped out: No

Reporting methods: Registry/QCDR

Maximum points: 10

Measure purpose: A significant proportion of psoriasis patients who are receiving treatment remain unsatisfied with their therapies, and treatment dissatisfaction can lead to patients discontinuing their medication. This measure evaluates the proportion of psoriasis vulgaris patients receiving systemic medication who meet minimal physician- or patient-reported disease activity levels to increase patient satisfaction and adherence to treatment.


The numerator: Patients who have a documented physician global assessment (PGA; 5-point OR 6-point scale), body surface area (BSA), psoriasis area and severity index (PASI) and/or dermatology life quality index (DLQI) that meet any one of the specified benchmarks:

  • PGA (5-point OR 6-point scale) ≤ 2 (clear to mild skin disease)
  • BSA < 3% (mild disease)
  • PASI < 3 (no or minimal disease)
  • DLQI ≤ 5 (no effect or small effect on patient’s quality of life)


The denominator: All patients with a diagnosis of psoriasis vulgaris who are treated with a systemic medication.

Measure calculation example

Dr. Chen saw 47 patients who have a diagnosis of psoriasis vulgaris and receive systematic medications during the reporting period. This is the denominator. Of the 47 patients, 31 have a documented physician global assessment, BSA, PASI, and/or DLQI that meet one of the specified benchmarks. This is the numerator.

Quality of patient care = 31/47. Dr. Chan has a score of 66% for this measure. This translates to 6.0 to 6.9 points.

Important note

Important note: Because of how this measure is structured, physicians score 3 points even if they report on only one patient. Physicians receive no additional score for reporting scores that fall below 23.08%. For example, if Dr. Chen reported on one patient encounter she would earn 3 points.

Click on the image to download PDF.

Training on psoriasis assessment tools 

The American Academy of Dermatology and the Group for Research and Assessment for Psoriasis and Psoriatic Arthritis (GRAPPA) collaborated to provide free short educational videos on how to use psoriasis assessment tools.


Introduction to psoriasis assessment  tools for MIPS #410 ( 3:55 minutes)  

Download PDF version


Body Surface Area (BSA)  (2:22 minutes) 

Download PDF version


Dermatology Life Quality Index (DLQI)  (2:33 minutes)  

Download PDF version


Physician Global Assessment (PGA)  (5:33 minutes)

Download PDF version


Psoriasis Area and Severity Index (PASI) (10:59 minutes) 

Quality measure score benchmark

CMS will award points based on a comparison of your performance rate to CMS benchmarks listed below. Reach the performance rate listed to achieve the corresponding points per measure. Points achieved for the Quality category will account for 45% of the overall MIPS score.

Below 3Decile 3Decile 4Decile 5Decile 6Decile 7Decile 8Decile 9Decile 10
Performance rate 1 patient 23.08-
Points 3 points 3 - 3.9 4 - 4.9 5 - 5.9 6 - 6.9 7 - 7.9 8 - 8.9 9 - 9.9 10